N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects. - Wikidata - wikimedia - TriplyDB

N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects.

N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects.

http://www.wikidata.org/entity/Q39833920

about

Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.Fucosylation is a promising target for cancer diagnosis and therapy Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies N-linked glycan changes of serum haptoglobin β chain in liver disease patients.Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.Longitudinal study of circulating protein biomarkers in inflammatory bowel disease.Aberrant glycosylation associated with enzymes as cancer biomarkers.N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.Alpha-1 antitrypsin is markedly decreased following pulmonary F. tularensis challenge Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios Acute phase glycoproteins: bystanders or participants in carcinogenesis?The role of glycosylation in IBD.Insights on N-glycosylation of human haptoglobin and its association with cancers.Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery.Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC/MS and LC/MS/MS.Identification of proteins with the CDw75 epitope in human colorectal cancer.Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung diseases by capillary electrophoresis.Fucosylation is associated with the malignant transformation of intraductal papillary mucinous neoplasms: a lectin microarray-based study.The Haptoglobin β chain as a supportive biomarker for human lung cancers.Carbohydrate Biomarkers

P2860

Q30382105-D79DD5D3-607F-4A2D-9542-5D066030BDE7 Q33649601-515B2DD0-21BB-48E1-96E4-E68386E012AF Q33762901-08F4C3C9-59D9-4BDF-BDD2-BDF2BB0923A8 Q33838472-F6F6C033-8496-4389-AD29-528DCE4F103F Q33850105-EEBB4BF2-B0AE-41C9-98F7-078F42F57E93 Q34058682-F0446730-678F-45D3-9AAF-B43B52AE4A75 Q35032838-3841F41C-18F9-422B-8087-A729A173F7C4 Q35206309-6A879EA3-DE2E-4738-A7C1-B2701ADF9FDE Q35874750-81988BF6-1A8D-46C8-86C9-A4DC0B159EB4 Q36158780-97D3EAF6-891F-45DA-A61A-00074219CCCD Q37738102-A070630E-6AE9-4CA2-A1FE-AB8443DD2266 Q37986822-7CBD4983-F5CF-477B-A665-98DE09B9E97E Q38218832-FCE13C9E-FC07-43C9-8E54-727C6E8C6093 Q38731700-C2728E6D-2275-42BF-AB79-7C430A2AB5F5 Q39373031-A8CE32E4-070A-42F7-A7EA-CDFB406A9844 Q45366283-7D61C8ED-6F55-40B5-980C-2E9E8B7140F9 Q47213195-85FE25CA-500B-43BE-80D1-2E6884D1AA05 Q48251620-D5E59FDF-FAAC-4850-924D-52624232D5C8 Q48515818-BF37AA6D-98C6-44F9-88F7-4387DEA560FF Q51072346-D0D8BB02-6FEA-4C7A-B8A2-041D08AB302F Q53208028-CA8E1E8C-4DAC-4C63-A64F-E4F1F8D9DFE7 Q53441687-9FE94B4C-3C24-47DA-8C7A-7A258572F279 Q57696972-BD454BB1-DE84-4E45-9A7C-AA4C83E8939E

P2860

N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects.

http://www.wikidata.org/entity/Q39833920

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

N-glycosylation status of beta ...... diseases and normal subjects.

@en

N-glycosylation status of beta ...... diseases and normal subjects.

@nl

type

label

N-glycosylation status of beta ...... diseases and normal subjects.

@en

N-glycosylation status of beta ...... diseases and normal subjects.

@nl

prefLabel

N-glycosylation status of beta ...... diseases and normal subjects.

@en

N-glycosylation status of beta ...... diseases and normal subjects.

@nl

P1433

Q39833920-5A32B2F2-EFEE-440A-B319-32B5CE88A45A

P1476

Q39833920-F3263600-7D0C-4B16-911A-B7EB870E73CC

P2093

Q39833920-11EAE44C-2551-46D1-8ED0-B2787FC7D931

Q39833920-18A46F0E-F4A3-4C31-B737-5597A1B1F34A

Q39833920-3CD970D2-454F-4664-9428-042A408D277A

Q39833920-4445936C-47CE-47A9-9EAA-9F9FEF5F841C

Q39833920-6CFB1742-7A92-4FE3-BA8D-E19F1415096D

Q39833920-955FAD28-C707-4C72-AE8D-E5C81A84D85C

Q39833920-C9BBA999-DB30-41EC-953B-7F92CB34D619

Q39833920-E7420DE2-BE37-4DF0-AB4B-041900C58B3C

Q39833920-E9B165C5-A69F-4441-B4A2-65EE2DA4DF4A

Q39833920-EB43E0F6-16C4-4793-B302-374906DC8C81

P2860

Q39833920-01888392-5E00-44EA-B756-8665A1AFF851

Q39833920-0AFBE7CB-3AD8-45F9-9C16-74A0FF407CCB

Q39833920-20072AC1-6550-4557-9A0B-1374038F1164

Q39833920-4EEFF870-8E71-4E58-920A-6C2C29F57AA4

Q39833920-5008BE98-2A76-4B35-B464-FEBB39846B2D

Q39833920-5AFFCB4E-60CF-4DC2-B6EA-AC58872FF043

Q39833920-6AACA645-2F8F-4E33-BBE9-A47C4EB89368

Q39833920-78B93EBB-7FD8-472D-B9E3-7611CFF7C255

Q39833920-7C063A88-28A1-42DE-90B8-8B44E51D14C2

Q39833920-9DF5A638-E29F-4F03-8EE9-745752F60656

P304

Q39833920-4CC1EACA-C28F-4F35-9D5A-95F70920413E

P31

Q39833920-B8CEADA4-0A5E-46C0-808B-612B4621BE27

P356

Q39833920-103CC83E-103D-4480-A29F-70D385BE78C1

P433

Q39833920-B8A09B1D-C1ED-41AA-80EC-B0693A507B24

P478

Q39833920-CAD32AC2-5A9F-49B4-AF29-5B91BD9E6BC7

P577

Q39833920-39565B31-414F-46FA-A880-EF8C640A12E9

P5875

Q39833920-AEBE9487-B3D4-4723-8095-81491CF8AC28

P698

Q39833920-3DC98150-6647-474D-9A22-309B5B0CC46E

P921

Q39833920-2DCAD73C-9709-4683-A6BB-588349FB03DF

Q39833920-F34BB888-B8AD-4532-A7DF-EE8952A12559

P356

P1433

International Journal of Cancer

P1476

N-glycosylation status of beta ...... diseases and normal subjects.

@en

P2093

Bradford Bernert

http://www.w3.org/2001/XMLSchema#string

Ji-Yeon Kim

http://www.w3.org/2001/XMLSchema#string

Jin-Man Kim

http://www.w3.org/2001/XMLSchema#string

Jung-Hoe Kim

http://www.w3.org/2001/XMLSchema#string

Sen-itiroh Hakomori

http://www.w3.org/2001/XMLSchema#string

Seon-Joo Yoon

http://www.w3.org/2001/XMLSchema#string

Seung-Yeol Park

http://www.w3.org/2001/XMLSchema#string

Steven H Itzkowitz

http://www.w3.org/2001/XMLSchema#string

Thomas Ullman

http://www.w3.org/2001/XMLSchema#string

Yeon-Tae Jeong

http://www.w3.org/2001/XMLSchema#string

P2860

Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.

Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection.

Glycosylation defining cancer malignancy: new wine in an old bottle

Traveling for the glycosphingolipid path.

Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene.

Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor.

N-glycosylation of serum proteins in disease and its investigation using lectins.

Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway.

Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).

Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1.

P304

142-155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.24685

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26316283

http://www.w3.org/2001/XMLSchema#string

P698

19551866

http://www.w3.org/2001/XMLSchema#string

P921